Specifically, we found the top two most frequently mutated genes to be SCN1A and MECP2. It has been reported that mutation of SCN1A is the most common mutation associated with epilepsy in the clinic (20), especially de novo mutations in drug-refractory epilepsy (27). This evidence concerns the gene SCN1A and epilepsy.